AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8477064
Drug: MEVP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEVP therapy (10 mg/m2 of mitoxantrone intravenously on day 1, 2 mg/m2 of vindesine intravenously on day 1, 200 mg/m2 of etoposide orally on days 1-3, and 40 mg/m2 of prednisolone orally on days 1-5, repeated every 3 weeks for up to 10 courses)
Trial: 8477064
Drug: CHOP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHOP therapy
Trial: 3513808
Drug: Control (Conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Conventional diuretic treatment)
Trial: 21946836
Drug: Infant formula
RxNorm normalized name: Infant formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infant formula with polydextrose (PDX) and galacto-oligosaccharides (GOS) (4 g/L, 1:1 ratio)
Trial: 18422771
Drug: Transdermal oestrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal oestrogen patches (Fem7, 100 microg)
Trial: 18422771
Drug: Luteinizing hormone-releasing
RxNorm normalized name: (6-D-Tryptophan)luteinizing hormone-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luteinizing hormone-releasing hormone agonist therapy
Trial: 8813896
Drug: Fructo-oligosaccharides 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructo-oligosaccharides 5 g/d
Trial: 8813896
Drug: Fructo-oligosaccharides 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructo-oligosaccharides 15 g/d
Trial: 8813896
Drug: Fructo-oligosaccharides (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructo-oligosaccharides (both doses)
Trial: 1553890
Drug: Bepridil 300
RxNorm normalized name: bepridil 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bepridil 300 mg once/day
Trial: 3890587
Drug: Lofexidine (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lofexidine (0.4 mg orally every 6 hours for 48 hours)
Trial: 25880400
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg daily for 12 weeks
Trial: 26936232
Drug: Escitalopram 20
RxNorm normalized name: escitalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 20 mg daily for 12 weeks
Trial: 22821644
Drug: Telmisartan 80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 80 mg/day (Tel80)
Trial: 22821644
Drug: Telmisartan 40
RxNorm normalized name: telmisartan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 40 mg + Amlodipine 5 mg (Tel40 + Aml5)
Trial: 18073543
Drug: 5 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml/kg 20% mannitol
Trial: 9273829
Drug: Alcoholic beverage
RxNorm normalized name: Alcoholic beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcoholic beverage (0.56 g of alcohol per kg of body weight)
Trial: 9273829
Drug: Placebo beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo beverage (3 mL of alcohol)
Trial: 3223489
Drug: Comprehensive intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Comprehensive intervention (self-help manual, televised broadcast, weekly support meetings, supportive phone calls)
Trial: 2277739
Drug: Inhaled albuterol
RxNorm normalized name: albuterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled albuterol and systemic corticosteroids
Trial: 2277739
Drug: Inhaled albuterol
RxNorm normalized name: albuterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled albuterol and placebo
Trial: 28303470
Drug: Xylitol chewing
RxNorm normalized name: xylitol Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylitol chewing gum (2.5 g/day)
Trial: 22732766
Drug: Vardenafil (20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil (20, 10 or 5 mg single oral doses)
Trial: 16759047
Drug: Immediate enfuvirtide/optimized‐background
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate enfuvirtide/optimized‐background treatment regimen
Trial: 16759047
Drug: 16‐week treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16‐week treatment interruption followed by enfuvirtide/optimized‐background treatment regimen
Trial: 11699489
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of HTR and ePTFE
Trial: 7952370
Drug: Independent weekly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Independent weekly assessments
Trial: 28699886
Drug: IL-1 trap
RxNorm normalized name: IL-1 TRAP
DrugBank: Rilonacept (DB06372)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-1 trap rilonacept (160 mg/week) for 12 weeks
Trial: 16981859
Drug: Double-dose CEE/MPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose CEE/MPA (conjugated equine estrogens plus medroxyprogesterone acetate, 0.625 mg + 2.5 mg) daily
Trial: 16981859
Drug: Single-dose CEE/MPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose CEE/MPA (0.625 mg + 2.5 mg) daily
Trial: 16981859
Drug: CEE/MPA (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE/MPA (both doses)
Trial: 11740262
Drug: G-CSF (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF (2 microg/kg subcutaneously once a day for 5 days)
Trial: 30942028
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (once a day, 5 treatments a week for 4 weeks) at points Baihui (BL 20), Fengchi (GB 20), Pishu (BL 20), Shenshu (BL 23), Sanyinjiao (SP 6), Taixi (KI 3)
Trial: 28426260
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg dapagliflozin
Trial: 19491213
Drug: Daily intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily intake of a combination pill of 2.5 mg folic acid, 50 mg vitamin B6, and 1 mg vitamin B12
Trial: 12739919
Drug: Nutrition counseling
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition counseling plus a nutritional supplement (Study) for 90 days
Trial: 12739919
Drug: Nutrition counseling
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition counseling plus a nutritional supplement (Study)
Trial: 8832480
Drug: Flap debridement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flap debridement surgery + 100 mg/ml TTC solution and FFSS application
Trial: 3871235
Drug: Urea treatment
RxNorm normalized name: Urea
DrugBank: Urea (DB03904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urea treatment during cardiopulmonary bypass
Trial: 27367745
Drug: Prednisolone acetate
RxNorm normalized name: Prednisolone Acetate
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone acetate 1% four times daily
Trial: 21901316
Drug: 1,017 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,017 μg salvinorin A
Trial: 21901316
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg salvinorin A
Trial: 17114190
Drug: MM-093 (21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MM-093 (21 mg weekly subcutaneous injections)
Trial: 16623018
Drug: Diabetes drug
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes drug counseling by pharmacist, diabetes booklet, and special medication containers
Trial: 16623018
Drug: Diabetes drug
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes drug counseling by pharmacist
Trial: 16623018
Drug: All interventions
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All interventions (drug counseling, booklet, containers)
Trial: 9164416
Drug: Delavirdine mesylate
RxNorm normalized name: Delavirdine Mesylate
DrugBank: Delavirdine (DB00705)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delavirdine mesylate (400 mg every 8 hours for 30 days) + Rifampin (600 mg once-daily on days 16-30)
Trial: 1774018
Drug: Constant rate
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant rate iv infusion of insulin (0.034 U/kg/h) during 150 minutes
Trial: 1774018
Drug: Identical infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Identical infusion of insulin with variable iv infusion of glucose to maintain euglycemia
Trial: 28412602
Drug: Medication management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication management plus instructions in CBT
Trial: 26781346
Drug: Mecapegfilgrastim 100
RxNorm normalized name: Mecapegfilgrastim
DrugBank: Mecapegfilgrastim (DB19147)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mecapegfilgrastim 100 μg/kg
Trial: 26781346
Drug: Mecapegfilgrastim 6
RxNorm normalized name: pegfilgrastim
DrugBank: Pegfilgrastim (DB00019)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Mecapegfilgrastim 6 mg fixed dose
Trial: 26781346
Drug: Daily rhG-CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily rhG-CSF
Trial: 12047460
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (SV) 1000-2000 mg/day
Trial: 7745334
Drug: Bismuth subgallate
RxNorm normalized name: Bismuth subgallate
DrugBank: Bismuth subgallate (DB13909)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth subgallate as a haemostatic agent
Trial: 2039103
Drug: Rectal thiopental
RxNorm normalized name: thiopental Rectal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal thiopental 25 mg/kg
Trial: 2039103
Drug: Drug combination
RxNorm normalized name: Other anti-dementia drug combinations in ATC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug combination (meperidine 2 mg/kg, promethazine 1 mg/kg, chlorpromazine 1 mg/kg)
Trial: 2039103
Drug: Drug combination
RxNorm normalized name: Other anti-dementia drug combinations in ATC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug combination
Trial: 23302898
Drug: Preemptive pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive pain medication and intraoperative periarticular injections (Group I)
Trial: 23302898
Drug: Not receiving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not receiving preemptive medication and injections (Group II)
Trial: 22766210
Drug: Group I:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group I: Fentanyl 2 mg/kg + Pentothal 5 mg/kg + Vecuronium 0.1 mg/kg
Trial: 22766210
Drug: Group II:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group II: Lidocaine 1.5 mg/kg + Fentanyl 2 mg/kg + Pentothal 5 mg/kg + Vecuronium 0.1 mg/kg
Trial: 22766210
Drug: Group III:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group III: Lidocaine 1.5 mg/kg + Pentothal 5 mg/kg + Vecuronium 0.1 mg/kg
Trial: 2347035
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (two intradermal injections on days 0, 3, and 7)
Trial: 2347035
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (one intradermal and one subcutaneous injection on days 0, 3, and 7)
Trial: 2347035
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (two subcutaneous injections on days 0, 3, and 7)
Trial: 465440
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g guar gum in bread
Trial: 465440
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g guar gum in soup
Trial: 465440
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g guar gum (5 g in bread and 5 g in soup)
Trial: 30632290
Drug: Teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide 20 μg subcutaneous daily for 12 months
Trial: 17874921
Drug: Multisystemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multisystemic therapy with high treatment fidelity
Trial: 17874921
Drug: Multisystemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multisystemic therapy with low treatment fidelity
Trial: 9758290
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg trovafloxacin once daily
Trial: 9758290
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg trovafloxacin once daily
Trial: 9758290
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg amoxicillin three times daily
Trial: 9758290
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg trovafloxacin
Trial: 9758290
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg trovafloxacin
Trial: 8152575
Drug: Tropisetron 5
RxNorm normalized name: tropisetron 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 5 mg/day (IV before chemotherapy and orally for 4 days)
Trial: 8152575
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg x 3/day (first dose IV before chemotherapy and subsequent doses orally until the end of the fourth day after chemotherapy)
Trial: 3072830
Drug: S-carboxymethylcysteine (S-CMC)
RxNorm normalized name: S-carboxymethylcysteine
DrugBank: Carbocisteine (DB04339)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-carboxymethylcysteine (S-CMC) syrup
Trial: 23181712
Drug: Ingesting all
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ingesting all medications upon awakening
Trial: 23181738
Drug: Ingesting ≥1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ingesting ≥1 medications at bedtime
Trial: 23181712
Drug: Ingesting all
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ingesting all medications at bedtime
Trial: 23181712
Drug: Bedtime treatment
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime treatment with ARBs
Trial: 23181712
Drug: Bedtime treatment
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime treatment with calcium channel blockers
Trial: 23181712
Drug: Ingesting ≥1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ingesting ≥1 medications at bedtime (specifically ARBs)
Trial: 19932838
Drug: Dexamethasone 10
RxNorm normalized name: dexamethasone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10 mg/kg (group D)
Trial: 19932838
Drug: Dexamethasone 10
RxNorm normalized name: dexamethasone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10 mg and midazolam 0.075 mg/kg (group DM)
Trial: 9350955
Drug: Quetiapine (407
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (407 mg mean daily dose)
Trial: 9350955
Drug: Chlorpromazine (384
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (384 mg mean daily dose)
Trial: 8405016
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of pantoprazole (40 mg)
Trial: 8405016
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of pantoprazole (40 mg)
Trial: 3535986
Drug: Large dose
RxNorm normalized name: Largemouth bass
DrugBank: Largemouth bass (DB10976)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large dose of caffeine (15 mg X kg‐1)
Trial: 3535986
Drug: Small dose
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small dose of caffeine (10 mg X kg‐1)
Trial: 28230029
Drug: Gemcitabine 1000
RxNorm normalized name: gemcitabine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1000 mg/m2 + nedaplatin 20 mg/m2, administered on day 1 and 8 with 21 days per cycle for 3 cycles
Trial: 28230029
Drug: 5-fluorouracil 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil 500 mg/m2 + cisplatin 20 mg/m2, administered on day 1-5 with 21 days per cycle for 3 cycles
Trial: 20532476
Drug: Metformin (RECORD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (RECORD trial)
Trial: 15877299
Drug: Fenofibrate 250
RxNorm normalized name: fenofibrate 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 250 mg/d
Trial: 8723576
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa 300 IU/kg intravenous (i.v.) twice weekly for 3 weeks
Trial: 8723576
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa 100 IU/kg subcutaneous (s.c.) twice weekly for 3 weeks (with a single i.v. bolus of 200 IU/kg at the first s.c. dose)
Trial: 8723576
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (i.v. and s.c. epoetin alfa)
Trial: 6362676
Drug: Kelfiprim (trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kelfiprim (trimethoprim 250 mg + sulfalene 200 mg)
Trial: 6362676
Drug: Co-trimoxazole (trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (trimethoprim 320 mg + sulfamethoxazole 1600 mg)
Trial: 29210520
Drug: MMN (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMN (18 vitamins and minerals including 250 μg iodine per day)
Trial: 29210520
Drug: LNS (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LNS (20 g/day of small-quantity lipid-based nutrient supplements with 250 μg iodine)
Trial: 29210520
Drug: IFA (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFA (60 mg iron and 400 μg folic acid per day)
Trial: 18186579
Drug: Crude rhubarb
RxNorm normalized name: RHUBARB
DrugBank: Rhubarb (DB10651)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crude rhubarb treatment (3 g, tid, p.o)
Trial: 18186579
Drug: Crude rhubarb
RxNorm normalized name: RHUBARB
DrugBank: Rhubarb (DB10651)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crude rhubarb treatment
Trial: 15073700
Drug: Aminocaproic acid
RxNorm normalized name: Aminocaproic Acid
DrugBank: Aminocaproic acid (DB00513)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aminocaproic acid (100 mg/kg after anesthetic induction, 100 mg/kg on CPB, and 100 mg/kg after protamine)
Trial: 15073700
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (10 mg/kg after anesthetic induction, 10 mg/kg on CPB, and 10 mg/kg after protamine)
Trial: 11752035
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibition (ACEi) with enalapril 5 mg once daily
Trial: 9721002
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (20 g x day(‐1), given in 4 x 6‐g doses of 5 g creatine monohydrate and 1 g glucose for 5 days)
Trial: 2506966
Drug: Topical steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroids and mydriatics (Control)
Trial: 28258434
Drug: USG-guided corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: USG-guided corticosteroid injection (40 mg/2 mL methylprednisolone acetate)
Trial: 28258434
Drug: Blinded corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blinded corticosteroid injection (40 mg/2 mL methylprednisolone acetate)
Trial: 21544005
Drug: Intravenous ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous ribavirin (RBV) at a moderate dose (8.33 mg/kg/dose q 8 hours on day 1, 5 mg/kg/dose q 8 hours on days 2-10)
Trial: 21544005
Drug: Intravenous ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous ribavirin (RBV) at an escalated dose (33 mg/kg on day 1, then 16 mg/kg/dose q 6 hours for 4 days, and 8 mg/kg/dose q 8 hours for 3 days)
Trial: 18297416
Drug: Fluoxetine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine plus gabapentin
Trial: 31944487
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose tDCS (2.5 mA for 30 min)
Trial: 31944487
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose tDCS (0.034 mA for 30 min)
Trial: 30139638
Drug: IBI-10090 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IBI-10090 (5 μL injection of 517 μg)
Trial: 30139638
Drug: Prednisolone acetate
RxNorm normalized name: Prednisolone Acetate
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone acetate 1.0% (1 drop 4 times daily for 3 weeks)
Trial: 25721132
Drug: Sensor-based interactive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensor-based interactive exercise training (twice a week for 4 weeks)
Trial: 23553157
Drug: Low-sodium diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium diet (1.3 g/d)